Literature DB >> 16502531

Lucrative niches: how drugs for rare diseases became lifeline for companies.

Geeta Anand.   

Abstract

Keywords:  Health Care and Public Health; Orphan Drug Act; Popular Approach/Source

Mesh：

Year:  2005        PMID： 16502531

Source DB:  PubMed          Journal:  Wall St J (East Ed)        ISSN： 0099-9660


× No keyword cloud information.
  5 in total

1.  Biosimilar growth hormone.

Authors:  Paul Saenger
Journal:  Indian J Pediatr       Date:  2011-11-23       Impact factor: 1.967

2.  Growth hormone and health policy.

Authors:  Leona Cuttler; J B Silvers
Journal:  J Clin Endocrinol Metab       Date:  2010-04-28       Impact factor: 5.958

3.  Demonstrating the value of biologics: a call to action.

Authors:  Jeff Clough
Journal:  Biotechnol Healthc       Date:  2007-08

4.  On specialty pharmaceuticals: reflections of a second-year medical student.

Authors:  Ross E Breitbart
Journal:  Biotechnol Healthc       Date:  2006-10

5.  The prevalence and cost of unapproved uses of top-selling orphan drugs.

Authors:  Aaron S Kesselheim; Jessica A Myers; Daniel H Solomon; Wolfgang C Winkelmayer; Raisa Levin; Jerry Avorn
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.